Robotic nerve ‘cuffs’ could help treat a range of neurological conditions
26 April 2024Researchers have developed tiny, flexible devices that can wrap around individual nerve fibres without damaging them.
Researchers have developed tiny, flexible devices that can wrap around individual nerve fibres without damaging them.
Proof of principle study suggests the age-associated decline of the remyelination process is reversible.
We like to think the human brain is special, something different from other brains and information processing systems, but a Cambridge professor set out to test that assumption – by conducting a live experiment using Twitter.
A Cambridge University researcher investigating eye cell transplants in the battle against glaucoma has been awarded £200,000 by the Fight for Sight charity.
The path from innovation to impact can be long and complex. Here we describe the 30-year journey behind the development of a drug now being used to treat multiple sclerosis.
Insight could lead to new therapies to repair damage caused by MS.
New treatments for glaucoma are a key priority in vision research. Advances in stem cell technology in Cambridge are helping to make this dream a reality.
Scientists have uncovered the underlying biological reason why locusts form migrating swarms. Their findings, reported in today's edition of Science, could be used in the future to prevent the plagues which devastate crops (notably in developing countries), affecting the livelihood of one in ten people across the globe.
The way a common virus hijacks the cell it infects could hold the clue to combating Parkinson's disease.
Cambridge neurologists have shown that an antibody used to treat leukaemia also limits and repairs the damage in multiple sclerosis.